EN HU
logo Tudóstér

Janka Eszter Anna

Janka Eszter Anna

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
61
Publications in DEA:
61
OA:
41
Date range:
2012-2024
2024
1.
Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E. A., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z. T., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
GeroScience. 46 (4), 3581-3597, 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
2.
Várvölgyi, T., Janka, E. A., Szász, I., Koroknai, V., Toka-Farkas, T., Szabó, I. L., Ványai, B., Szegedi, A., Emri, G., Balázs, M.: Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, (article identifier: 174), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Medicine (miscellaneous) (2023)
3.
Schwarcz, S., Nyerges, P., Bíró, T. I., Janka, E. A., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
Molecules. 29 (13), 1-16, (article identifier: 3073), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Analytical Chemistry (2023)
Q1 Chemistry (miscellaneous) (2023)
Q2 Drug Discovery (2023)
Q2 Medicine (miscellaneous) (2023)
Q3 Molecular Medicine (2023)
Q2 Organic Chemistry (2023)
Q1 Pharmaceutical Science (2023)
Q2 Physical and Theoretical Chemistry (2023)
4.
Tári, V., Janka, E. A., Emri, G., Nemes, B. Á., Remenyik, É., Gellén, E.: Effect of education on sun-safe behaviour in kidney transplant recipients.
Photodermatol. Photoimmunol. Photomed. 40 (3), 1-8, (article identifier: 12966), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Dermatology (2023)
Q3 Immunology (2023)
Q3 Immunology and Allergy (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Radiology, Nuclear Medicine and Imaging (2023)
5.
Szász, I., Koroknai, V., Várvölgyi, T., Pál, L., Szűcs, S., Pikó, P., Emri, G., Janka, E. A., Szabó, I. L., Ádány, R., Balázs, M.: Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.
Int. J. Mol. Sci. 25 (8), 1-15, (article identifier: 4251), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis (2023)
Q1 Computer Science Applications (2023)
D1 Inorganic Chemistry (2023)
Q1 Medicine (miscellaneous) (2023)
Q2 Molecular Biology (2023)
D1 Organic Chemistry (2023)
Q1 Physical and Theoretical Chemistry (2023)
D1 Spectroscopy (2023)
6.
Janka, E. A., Szabó, I. L., Kollár, S., Toka-Farkas, T., Ványai, B., Várvölgyi, T., Kapitány, A., Shabu, H., Szegedi, A., Emri, G.: Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
Cancers (Basel). 16, 1-18, (article identifier: 2981), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research (2023)
Q1 Oncology (2023)
7.
Ghani, M., Szabó, B., Alkhatibe, M., Amsalu, H., Zohar, P., Janka, E. A., Mótyán, J. A., Tar, K.: Serine 39 in the GTP-binding domain of Drp1 is involved in shaping mitochondrial morphology.
FEBS Open Bio. 14 (7), 1147-1165, 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
2023
8.
Palatka, R., Janka, E. A., Soltész, L., Szabó, I. L., Kapitány, A., Dajnoki, Z., Emri, G., Nagy, G., Palatka, K., Zouboulis, C. C., Szegedi, A., Gáspár, K.: Chronic inflammatory intestinal disorders in hidradenitis suppurativa.
Dermatology. 239 (4), 592-600, 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Dermatology
9.
Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E. A., Sipos, A., Hegedűs, C., Uray, K., Nagy, P., Bai, P.: Identification of bacterial metabolites modulating breast cancer cell proliferation and epithelial-mesenchymal transition.
Molecules. 28 (15), 1-18, (article identifier: 5898), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
10.
Jankó, L., Tóth, E., Laczik, M., Rauch, B., Janka, E. A., Bálint, B. L., Bai, P.: PARP2 poly(ADP-ribosyl)ates nuclear factor erythroid 2-related factor 2 (NRF2) affecting NRF2 subcellular localization.
Sci. Rep. 13 (7869), 1-13, (article identifier: 7869), 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Multidisciplinary
11.
Janka, E. A., Ványai, B., Szabó, I. L., Toka-Farkas, T., Várvölgyi, T., Kapitány, A., Szegedi, A., Emri, G.: Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
Front Oncol. 13, 1-11, (article identifier: 1237643), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q2 Oncology
2022
12.
Antal, D., Janka, E. A., Szabó, J., Szabó, I. L., Szegedi, A., Gáspár, K., Bai, P., Szántó, M.: Culture-based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients.
J. Eur. Acad. Dermatol. Venereol. 36 (9), e731-e733, 2022.
doi DEA WoS Scopus
Journal metrics:
D1 Dermatology
Q1 Infectious Diseases
13.
Molnár, S., Hunya, Z., Gáspár, K., Szerb, I., Szabó, N., Mensch, K., Körösi, É., Bacskai, K., Sántha, Á. K., Janka, E. A., Shadgan, B.: Moderate and Severe Injuries at Five International Olympic-Style Wrestling Tournaments during 2016-2019.
J. Sports Sci. Med. 21, 74-81, 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Orthopedics and Sports Medicine
Q1 Physical Therapy, Sports Therapy and Rehabilitation
Q2 Sports Science
14.
Kacsir, I., Sipos, A., Bényei, A., Janka, E. A., Buglyó, P., Somsák, L., Bai, P., Bokor, É.: Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
Int. J. Mol. Sci. 23 (2), 1-39, (article identifier: 813), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
15.
Janka, E. A., Ványai, B., Dajnoki, Z., Szabó, I. L., Reibl, D., Komka, I., Blasszauer, C., Várvölgyi, T., Szegedi, A., Emri, G.: Regional variability of melanoma incidence and prevalence in Hungary. Epidemiological impact of ambient UV radiation and socioeconomic factors.
Eur. J. Cancer Prev. 31 (4), 377-384, 2022.
doi DEA WoS Scopus
Journal metrics:
Q3 Cancer Research
Q3 Epidemiology
Q3 Oncology
Q2 Public Health, Environmental and Occupational Health
2021
16.
Hegedűs, C., Juhász, T., Fidrus, E., Janka, E. A., Juhász, G., Boros, G., Paragh, G. J., Uray, K., Emri, G., Remenyik, É., Bai, P.: Cyclobutane pyrimidine dimers from UVB exposure induce a hypermetabolic state in keratinocytes via mitochondrial oxidative stress.
Redox Biol. 38, 1-17, 2021.
DEA WoS Scopus
Journal metrics:
D1 Biochemistry
D1 Clinical Biochemistry
D1 Organic Chemistry
17.
Töröcsik, D., Fazekas, F., Póliska, S., Gregus, A., Janka, E. A., Dull, K., Szegedi, A., Zouboulis, C. C., Kovács, D.: Epidermal Growth Factor Modulates Palmitic Acid-Induced Inflammatory and Lipid Signaling Pathways in SZ95 Sebocytes.
Front. Immunol. 12, 1-16, 2021.
doi DEA WoS Scopus
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
18.
Fidrus, E., Hegedűs, C., Janka, E. A., Paragh, G., Emri, G., Remenyik, É.: Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis - an In Vitro Study.
Int. J. Mol. Sci. 22 (4), 1-17, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
19.
Szentkereszty-Kovács, Z., Fiatal, S., Janka, E. A., Kovács, D., Szegedi, A., Remenyik, É., Töröcsik, D.: Leptin Receptor (rs1137101) and Brain-Derived Neurotrophic Factor (rs925946) Gene Variants Are Associated with Obesity in the Early- but Not in the Late-Onset Population of Hungarian Psoriatic Patients.
Life (Basel). 11 (10), 1-14, 2021.
doi DEA
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Ecology, Evolution, Behavior and Systematics
Q2 Paleontology
Q3 Space and Planetary Science
20.
Janka, E. A., Várvölgyi, T., Sipos, Z., Soós, A., Hegyi, P. J., Kiss, S., Dembrovszky, F., Csupor, D., Kéringer, P., Pécsi, D., Solymár, M., Emri, G.: Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: a Systematic Review and Meta-Analysis.
Front Oncol. 11, 1-11, 2021.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
2020
21.
Gáspár, K., Jenei, A., Khasawneh, A., Retzlerné Medgyesi, B., Dajnoki, Z., Janka, E. A., Szabó, I. L., Hendrik, Z., Méhes, G., Szegedi, A., Kapitány, A.: Comparison of Immune and Barrier Characteristics in Scalp and Skin Psoriasis.
Acta Derm.-Venereol. 100 (14), 1-7, 2020.
doi DEA
Journal metrics:
Q1 Dermatology
Q1 Medicine (miscellaneous)
22.
Hegedűs, C., Boros, G., Fidrus, E., Kis, G., Antal, M., Juhász, T., Janka, E. A., Jankó, L., Paragh, G. J., Emri, G., Bai, P., Remenyik, É.: PARP1 Inhibition Augments UVB-Mediated Mitochondrial Changes-Implications for UV-Induced DNA Repair and Photocarcinogenesis.
Cancers (Basel). 12 (1), 5, 2020.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
23.
Retzlerné Medgyesi, B., Dajnoki, Z., Béke, G., Gáspár, K., Szabó, I. L., Janka, E. A., Póliska, S., Hendrik, Z., Méhes, G., Töröcsik, D., Bíró, T., Kapitány, A., Szegedi, A.: Rosacea is Characterized by a Profoundly Diminished Skin Barrier.
J. Invest. Dermatol. 140 (10), 1938-1950, 2020.
doi DEA WoS Scopus
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
D1 Dermatology
Q1 Molecular Biology
2019
24.
Gellén, E., Fidrus, E., Janka, E. A., Kollár, S., Paragh, G. J., Emri, G., Remenyik, É.: 5-Aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: changes in immune infiltration.
Photodiagnosis Photodyn. Ther. 26, 270-276, 2019.
doi DEA
Journal metrics:
Q2 Biophysics
Q2 Dermatology
Q3 Oncology
Q2 Pharmacology (medical)
25.
Márton, É., Lukács, J., Penyige, A., Janka, E. A., Hegedüs, L., Soltész, B., Méhes, G., Póka, R., Nagy, B., Szilágyi, M.: Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.
J. Biotechnol. 297, 58-65, 2019.
doi DEA WoS Scopus
Journal metrics:
Q1 Applied Microbiology and Biotechnology
Q2 Bioengineering
Q1 Biotechnology
Q1 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.